7-Methoxy-4-oxo-1,4-dihydroquinoline-2-carboxylic acid, 95.0%, 250mg

1-(diazyn-1-ium-1-yl)-13-[(2,5-dioxopyrrolidin-1-yl)oxy]-13-oxo-4,7,10-trioxa-1-azatridecan-1-ide, 98%, 5g

1-Bromo-2-fluoro-4-methoxy-3-methylbenzene, 98%, 1g

tert-Butyl trans-4-ethynylcyclohexylcarbamate, 95%, 5g

2-(tert-Butoxycarbonyl)-2-azabicyclo[2.1.1]hexane-5-carboxylic acid, 95%, 250mg

Matraces de sulfuración, 2500 ml, 71/51, 29/32, 1 Pieza

Isavuconazole>98.0%(HPLC)(qNMR)250mg

4-Iodo-o-xylene, 98.0%, 500g

methyl 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxylate hydrochloride, 95.0%, 250mg

1-(2-Phenoxyphenyl)methanamine hydrochloride, 95.0%, 5g

(3aS,6aS)-tert-Butyl 3a-(hydroxymethyl)hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate, 98%, 1g

(3R)-(+)-3-Aminopyrrolidine>98.0%(GC)(T)25g

3-(3,4-dichlorophenyl)acrylic acid, 95, 100g